In this episode, our guest, (Founder & CEO of Sapient) - Dr. Jain is a physician-scientist with more than 20 years of expertise in physiology, biomedicine, engineering, computational biology, and mass spectrometry-based metabolomics. He formed and managed Jain Laboratory at the University of California San Diego, where he guided a multi-disciplinary research team to develop next-generation rapid liquid chromatography-mass spectrometry (rLC-MS) systems to probe the non-genetic landscape of disease across large-scale human studies.

Talking Points:

• 3 reasons genetics alone are not enough to personalize medicine.
• New methods for biomarker discovery, validation, & translation for clinical impact.
• The pitfalls of drug development and how they should be improved.
  
  

Guest - Dr. Mohit Jain

www.sapient.bio 

Twitter

LinkedIn

YouTube

Web

Host - Hillary Blackburn, PharmD, MBA

• www.hillaryblackburn.com  
• https://www.linkedin.com/in/hillary-blackburn-67a92421/ 
• @talktoyourpharmacist for Instagram and Facebook
• @HillBlackburn Twitter/X